1.38
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.37 -0.010 -0.72%
loading

Achilles Therapeutics Plc Adr Aktie (ACHL) Neueste Nachrichten

pulisher
Feb 28, 2025

Achilles Therapeutics plans to leave Nasdaq and liquidate - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration - GlobeNewswire Inc.

Feb 28, 2025
pulisher
Feb 10, 2025

Check Out Achilles Therapeutics Plc ADR (ACHL)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Hut 8 Corp (HUT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Sprinklr Inc (CXM) - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

An Analysis of NovoCure Ltd (NVCR)’s Potential Price Growth - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

The Attractiveness of Investing In Enerflex Ltd (EFXT) is Growing - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Taking a Closer Look At VNET Group Inc ADR (VNET) Following Its Recent Trade - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

A Guide To The Risks Of Investing In Achilles Therapeutics Plc ADR (ACHL) - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Its Stock Has Paid Off Big Time For ASE Technology Holding Co.Ltd ADR - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Sacks Parente Golf Inc (SPGC) Shares Decline Despite Market Challenges - The News Heater

Feb 10, 2025
pulisher
Feb 06, 2025

Take off with Fate Therapeutics Inc (FATE): Get ready for trading - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Top investors say Lam Research Corp (LRCX) ticks everything they need - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

It is Poised to be a Bull Market for Allot Ltd (ALLT) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Stocks of Achilles Therapeutics Plc ADR (ACHL) are poised to climb above their peers - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Piper Sandler gives a Neutral recommendation for Achilles Therapeutics Plc ADR (ACHL) - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Do you want to know where to find good stock? Take a look at Achilles Therapeutics Plc ADR’s (NASDAQ:ACHL) Sentiment Analysis – US Post News - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

JMP Securities downgrades PJT Partners Inc (PJT) rating to a Mkt perform - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Hexcel Corp (HXL) receives an Outperform rating from RBC Capital Mkts - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Lloyds Banking Group plc ADR (LYG) rating downgrades by Morgan Stanley - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Did Caredx Inc (CDNA) perform well in the last session? - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Examining Immatics N.V (IMTX) more closely is necessary - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Achilles Therapeutics Plc ADR Inc. (ACHL) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

TPX’s 2023 Market Dance: Up 18.05% – Time to Invest? - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Rezolve AI Ltd: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Feb 04, 2025
pulisher
Dec 29, 2024

Head to Head Review: OPHIR ENERGY PL/ADR (OTCMKTS:OPHRY) vs. HOYA (OTCMKTS:HOCPY) - Defense World

Dec 29, 2024
pulisher
Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024
pulisher
Sep 23, 2024

ACHL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Sep 23, 2024
pulisher
Sep 20, 2024

why Achilles Therapeutics Plc ADR [ACHL] is a Good Choice for Investors After New Price Target of $1.25 - The DBT News

Sep 20, 2024
pulisher
Sep 20, 2024

What Analysts Were Expecting After PowerFleet Inc (NASDAQ: AIOT) rose 2.40% - Stocks Register

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics ends TIL-based cancer therapy trials - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

You Should Read This Analysis Before Investing in Achilles Therapeutics Plc ADR (NASDAQ:ACHL) - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles stock climbs on strategic focus (NASDAQ:ACHL) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics Announces Strategic Update - Yahoo Finance

Sep 19, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with - GlobeNewswire

May 22, 2024
pulisher
May 17, 2024

Achilles Therapeutics faces Nasdaq delisting over share price - Investing.com

May 17, 2024
pulisher
Jan 24, 2024

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 24, 2024
pulisher
Nov 13, 2023

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire

Nov 13, 2023
pulisher
Oct 24, 2023

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis - Yahoo Finance

Oct 24, 2023
pulisher
Nov 01, 2022

What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Yahoo Finance

Nov 01, 2022
pulisher
Oct 10, 2022

Apellis' (APLS) Empaveli Aids Growth, Stiff Competition a Woe - Yahoo Finance

Oct 10, 2022
pulisher
Sep 07, 2022

IVERIC bio (ISEE) Posts Positive Top-Line Data From GA Study - Yahoo Finance

Sep 07, 2022
pulisher
Sep 05, 2022

Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 - Yahoo Finance

Sep 05, 2022
pulisher
Aug 23, 2022

Novo (NVO) Posts Positive Data From Diabetes Study on CagriSema - Nasdaq

Aug 23, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Nov 19, 2020

Achilles Therapeutics Raises £52.7 Million in an - GlobeNewswire

Nov 19, 2020
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Kapitalisierung:     |  Volumen (24h):